NCT02201394View on ClinicalTrials.gov

Reversing Ticagrelor's Effects With Fresh Platelets

PHASE4CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

July 31, 2014

Primary Completion Date

June 30, 2016

Study Completion Date

June 30, 2016

Conditions
Coronary Artery Disease
Interventions
DRUG

Ticagrelor loading dose

Single loading dose of Ticagrelor 180 mg

DRUG

Aspirin loading dose

Single loading dose of Aspirin 325 mg

DRUG

Ticagrelor maintenance dose

Ticagrelor 90 mg twice daily x 7 days

DRUG

Aspirin maintenance dose

Aspirin 81 mg once daily x 7 days

Trial Locations (1)

10029

Icahn School of Medicine at Mount Sinai, New York

Sponsors

Collaborators (1)

AstraZeneca
All Listed Sponsors
collaborator

AstraZeneca

INDUSTRY

lead

Icahn School of Medicine at Mount Sinai

OTHER